550 related articles for article (PubMed ID: 15375023)
1. Nuclear receptor signaling and cardiac energetics.
Huss JM; Kelly DP
Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease.
Finck BN; Kelly DP
Circulation; 2007 May; 115(19):2540-8. PubMed ID: 17502589
[No Abstract] [Full Text] [Related]
3. Metabolic and genetic regulation of cardiac energy substrate preference.
Kodde IF; van der Stok J; Smolenski RT; de Jong JW
Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan; 146(1):26-39. PubMed ID: 17081788
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
5. The PPAR regulatory system in cardiac physiology and disease.
Finck BN
Cardiovasc Res; 2007 Jan; 73(2):269-77. PubMed ID: 17010956
[TBL] [Abstract][Full Text] [Related]
6. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis.
Lehman JJ; Boudina S; Banke NH; Sambandam N; Han X; Young DM; Leone TC; Gross RW; Lewandowski ED; Abel ED; Kelly DP
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H185-96. PubMed ID: 18487436
[TBL] [Abstract][Full Text] [Related]
8. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
9. PPAR signaling in the control of cardiac energy metabolism.
Barger PM; Kelly DP
Trends Cardiovasc Med; 2000 Aug; 10(6):238-45. PubMed ID: 11282301
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart.
Finck BN; Kelly DP
J Mol Cell Cardiol; 2002 Oct; 34(10):1249-57. PubMed ID: 12425323
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.
Willy PJ; Murray IR; Qian J; Busch BB; Stevens WC; Martin R; Mohan R; Zhou S; Ordentlich P; Wei P; Sapp DW; Horlick RA; Heyman RA; Schulman IG
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8912-7. PubMed ID: 15184675
[TBL] [Abstract][Full Text] [Related]
12. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.
Schilling J; Lai L; Sambandam N; Dey CE; Leone TC; Kelly DP
Circ Heart Fail; 2011 Jul; 4(4):474-82. PubMed ID: 21558447
[TBL] [Abstract][Full Text] [Related]
14. Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1.
Garcia MM; Guéant-Rodriguez RM; Pooya S; Brachet P; Alberto JM; Jeannesson E; Maskali F; Gueguen N; Marie PY; Lacolley P; Herrmann M; Juillière Y; Malthiery Y; Guéant JL
J Pathol; 2011 Nov; 225(3):324-35. PubMed ID: 21633959
[TBL] [Abstract][Full Text] [Related]
15. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
16. Diabetic cardiomyopathy.
Feuvray D
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and the control of fatty acid oxidation in cardiac hypertrophy.
Planavila A; Calvo RR; Vázquez-Carrera M
Mini Rev Med Chem; 2006 Mar; 6(3):357-63. PubMed ID: 16515475
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial energy metabolism in heart failure: a question of balance.
Huss JM; Kelly DP
J Clin Invest; 2005 Mar; 115(3):547-55. PubMed ID: 15765136
[TBL] [Abstract][Full Text] [Related]
19. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.
Schreiber SN; Emter R; Hock MB; Knutti D; Cardenas J; Podvinec M; Oakeley EJ; Kralli A
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6472-7. PubMed ID: 15087503
[TBL] [Abstract][Full Text] [Related]
20. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
Lahey R; Wang X; Carley AN; Lewandowski ED
Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
